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The ability of three primary amphipathic Cell-Penetrating Peptides (CPPs) CH3-CO-GALFLGFLGAAGSTMGAWSQPKKKRKV-NH-CH2-CH2-
SH, CH3-CO-GALFLAFLAAALS LMGLWSQPKKKRKV-NH-CH2-CH2-SH, and CH3-CO-KETWWETWWTEWSQPKKKRKV-NH-CH2-CH2-
SH called Pβ, Pα and Pep-1, respectively, to promote pore formation is examined both in Xenopus oocytes and artificial planar lipid bilayers. A good
correlation between pore formation and their structural properties, especially their conformational versatility, was established. This work shows that the
cell-penetrating peptides Pβ and Pep-1 are able to induce formation of transmembrane pores in artificial bilayers and that these pores are most likely at
the basis of their ability to facilitate intracellular delivery of therapeutics. In addition, their behaviour provides some information concerning the
positioning of the peptides with respect to the membrane and confirms the role of the membrane potential in the translocation process.
© 2006 Elsevier B.V. All rights reserved.Keywords: Cell-penetrating peptides; Conformation; Membrane uptake; Ionic channel; Amphipathic peptidesA number of natural and synthetic peptides are able to
translocate through various cell membranes and have been used
successfully to deliver hydrophilic molecules such as nucleic
acids or proteins into cells [1]. Most methods involve transport
of genes of interest into cells via the endosomal pathway,
leading to their rapid degradation in these acidic compartments
and therefore to their poor expression into the cytoplasm [2–6].
Alternatively, our group has designed peptide-based delivery
systems built of primary amphipathic sequences which can
deliver nucleic acids or proteins owing to the nature of their
hydrophobic sequence. Three peptides have been described so
far; MPG referred to hereafter as Pβ, Pα which derives from Pβ
by substitution of several residues within the hydrophobic
moiety and the tryptophan rich Pep-1. Pβ and Pαwere designed
for the delivery of nucleic acids [7,8] while Pep-1 is efficient for
delivery of proteins as well as PNAs [9,10].⁎ Corresponding author. Tel.: +33 4 67 61 33 92; fax: +33 4 67 52 15 59.
E-mail address: frederic.heitz@crbm.cnrs.fr (F. Heitz).
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doi:10.1016/j.bbamem.2006.08.010Pβ and Pα associate sequences derived from the hydro-
phobic fusion peptide of HIV gp41 and the hydrophilic nuclear
localization sequence (NLS) of SV40 large T antigen. These
peptides efficiently promote delivery of short oligonucleotides
such as siRNAs into a wide variety of cell lines independently
of the endosomal pathway [11]. In Pep-1 the hydrophobic
sequence is replaced by a sequence derived from the
dimerization domain of HIV-1 reverse transcriptase and also
delivers cargo proteins through a non-endosomal pathway [9].
Conformational investigations including mainly CD and
FTIR, together with cellular uptake of their Lucifer Yellow (Pβ
and Pα) or FITC (Pep-1) labelled derivatives were carried out
previously and can be summarized as follows:
Pβ: is not folded in solution in water but folds at least
partially into a sheet structure in the presence of a membrane-
mimicking medium irrespective of the nature of the phospho-
lipid [12] or of a nucleic acid cargo. The folded domain
corresponds to the hydrophobic sequence of the peptide. It
rapidly penetrates various cell lines finally localizing essentially
to the nucleus.
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and the helical domain concerns the hydrophobic sequence. In
contrast to Pβ, when incubated with cells, this peptide is only
detected inside endosomes, indicating a distinct internalization
pathway.
Pep-1: is a very versatile peptide. At low concentration in
water it is non-structured while an increase in its concentration
promotes folding into a helical conformation. Moreover,
interactions with membranes induce formation of a helical
fold but no cargo induced folding is observed at least with a
non-folded cargo. Like Pβ, Pep-1 enters cells rapidly and
ultimately localizes to the nucleus [13].
In order to gain a better insight into the mechanisms leading
to these final cellular localizations and to determine whether
these peptides or only some of them are able to induce
membrane leakage through formation of transient pore-like
structures, we investigated the possibility of pore formation
using two different approaches: the first involves patch clamped
Xenopus oocytes, the second a reconstituted planar bilayer
model.
On the basis of physico-chemical investigations mainly
including analyses of peptide conformations together with
studies of peptide–membrane interactions, two similar models
accounting for the membrane translocation mechanism have
recently been proposed: one accounts for Pβ [14] while the
second accounts for Pep-1 [13]. Both models involve formation
of transient pore-like structures and the main difference lies in
the structure of the peptides which associate to form the pore,
namely a β-barrel-like structure for Pβ, in contrast to a helical
fold for Pep-1. However, no model accounting for the properties
of Pα has been proposed so far and further, the existence of
pore-like structures requires confirmation, in particular through
electrophysiological measurements.
Here we describe the membrane transfer properties of three
peptides, which we correlate with their conformational states
and with their ability to induce pore formation when
incorporated into biological or reconstituted membranes,
thereby identifying specific criteria for further design of carrier
peptides with predefined internalization pathways.
1. Experimental procedures
1.1. Chemicals
Azolectine, Palmitoyloleoylphosphatidylcholine (POPC), Dioleoylphospha-
tidylethanolamine (DOPE) Dioleoylphosphosphatidylcholine (DOPC) andTable 1
Reversal potentials under different ionic conditions
Solution Pβ
no Main ion (mM) MgCl2 (mM) pH Mean Erev (m
1 NaCl: 100 2 7.2 NaOH −11.7±0.5
2 KCl: 100 2 7.2 KOH −9.2±0.9
3 TEACl: 100 2 7.2 TEAOH −16.9±0.4
4 NaAcetate: 100 2 7.2 NaOH −10.1±1.3
5 LiCl: 100 2 7.2 NaOH −13.2±0.5
6 CholineCl: 100 2 7.2 NaOH −11.7±0.2Dioleoylphosphatidylglycerol (DOPG) were purchased from Avanti Polar
Lipids (Alabaster, AL, USA).
1.2. Peptide synthesis
Peptides [Pβ] CH3-CO-GALFLGFLGAAGSTMGAWSQPKKKRKV-NH-
CH2-CH2-SH and [Pα] CH3-CO-GALFLAFLAAALSLMGLWSQPKKKRKV-
NH-CH2-CH2-SH were synthesized by solid-phase peptide synthesis using
AEDI-Expansin resin on a Pioneer peptide synthesizer (Applied Biosystems,
Foster City, CA) according to the Fmoc/tBoc method, as already described [15].
[Pep-1] CH3-CO-KETWWETWWTEWSQPKKKRKV-NH-CH2-CH2-SH was
synthesized by solid phase peptide synthesis using AEDI-Expansin resin on a
9050 PepSynthesizer (Millipore, Wartford, UK) according to the Fmoc/tBoc
method, as already described [9]. All peptides were acetylated at their N-
terminus and bear a cysteamide group at their C-terminus.
1.3. Electrophysiological measurements
1.3.1. Xenopus oocytes
Whole cell currents were recorded as described by Charnet et al. [16]
under a two-electrode voltage-clamp using the GeneClamp 500 amplifier
(Axon, Burlingame, CA). Current and voltage electrodes were filled with 3 M
KCl. The bath-clamp headstage was connected to the bath using two agar
bridges filled with 2% agar in 3 M KCl. Before each recording, electrode
resistance was checked to be less than 1 MΩ, and liquid junction potential
was zeroed.
The typical recording solution had the following composition (in mM):
NaCl, 100; HEPES, 10; MgCl2, 2; pH 7.2 with NaOH. Ionic selectivity of
peptide-induced channels was tested using the set of solutions described in Table
1. Currents were filtered and digitized using a DMA-Tecmar labmaster, and
subsequently stored in a computer using version 6.02 of the pClamp software
(Axon). Voltage ramps (from −80 to +80 mV during 450 ms) were applied from
the holding potential every 5 s.
From a fresh stock solution at 0.5 mM in water, the peptide was then
diluted in the appropriate solution at 10 μM and added directly (30 μl) to the
recording chamber (volume 150 μl with no dilution). Gravity-driven perfusion
was sometimes made without any significant difference. Reversal potentials
were measured as the zero-current potential. Correction for non-linear leak-
current was obtained by subtracting traces recorded before peptide
application. Junction potential between the different solutions used was less
than 2 mV.
1.3.2. Planar lipid bilayers
In macroscopic and single-channel conductance experiments, virtually
solvent-free planar lipid bilayers were formed by the Montal and Mueller
technique [17]. The membrane was formed over a 100–150 μm hole in a
Teflon film (10 μm thick), pretreated with a 1:40 mixture (v/v) of
hexadecane/hexane, separating two half glass-cells. After 2 h, lipid
monolayers were spread on top of electrolyte solution (1 M KCl, 10 mM
N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES) pH 7.4) in
both compartments. Azolectine or a mixture of palmitoyloleoylphosphocho-
line/dioleoylphosphoethanolamine/dioleoylphosphoethanolamine (POPC/
DOPE/DOPG, 7:3:1, v/v/v) was used as lipid. Bilayers were formed byPep-1
V) Number of oocytes Mean Erev (mV) Number of oocytes
16 −9.5±0.7 16
7 −6.7±0.3 6
7 −17.0±0.6 7
6 −10.9±0.9 6
10 −14.8±0.4 9
9 −15.6±1.1 9
Fig. 1. Ionic selectivity at the macroscopic level for Pβ (a) and Pep-1 (b).
Current traces were recorded under voltage ramps (−80 to +80 mV) applied at
different times after addition of 10 μM peptide to the bath solution.
Fig. 2. Macroscopic current–voltage (I–V) curves of Pα (pink), Pβ (cyan) and
Pep-1 (green) in azolectin bilayers. Voltage ramp when 10−7 M peptide is added
to both sides in the presence of KCl 1 M, as electrolyte buffered with 10 mM
HEPES (pH 7.4).
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monitoring capacitance responses. Voltage was applied through an Ag/AgCl
electrode on the cis-side. The peptide was added to both compartments,
typically at 10−11 to 10−10 M for single channel experiments or 10−8 to
10−7 M for macroscopic measurements.
In macroscopic conductance experiments, doped membranes were subjected
to slow voltage ramps (10 mV/s) and transmembrane currents were fed into an
amplifier (BBA-01, Eastern Scientific, Rockville, USA). Current–voltage
curves were stored on a computer and analyzed with Scope software (Bio-
Logic, Claix, France).
In single-channel recordings, currents were amplified and potentials were
applied simultaneously by a patch-clamp amplifier (RK 300, Bio-Logic).
Single-channel currents were monitored using an oscilloscope (TDS 3012,
Tektronix, Beaverton, USA) and stored on a CD recorder (DRA 200, Bio-Logic)
for off-line analysis. CD data were then analyzed by the Windac32 (http://www.
shareit.com) and Biotools (Bio-Logic) programs. All experiments were
performed at room temperature. Data were filtered at 300 Hz before digitizing
at 11.2 kHz for analysis.
2. Results
2.1. Xenopus oocytes
When added to oocytes bathed in the electrolyte solutions,
two different effects are detected. While no modification of
transmembrane current is induced by addition of Pα, both
Pβ and Pep-1 induce a significant increase in the
transmembrane current (Fig. 1). The reversal potentials
obtained for each peptide are reported in Table 1 and only
slight differences distinguish the two peptides which have
very similar ion selectivity (K+>Na+=Choline+>Li+>TEA+
for Pβ and K+>Na+>Li+ >Choline+>TEA+ for Pep-1) and
for both, the Cl− anion is not the ion driving the current. It
should also be noted that the same amount of each peptide
engaged in a complex with its respective cargo promotes a
decrease in transmembrane conductance without modification
of the reverse potential. Whether this decrease is due to an
artificial decrease in peptide available for formation of the
structure promoting the transmembrane current will require
further investigations. Nevertheless, it can be correlated with
the cytotoxicity of these peptide vectors. Indeed, it was
previously shown that, in the absence of cargo, the variouspeptides are cytotoxic in the μMolar range and that when
applied in the presence of a cargo, they are toxic in the
10 μMolar range [9,18].
2.2. Planar lipid bilayers
In parallel to the experiments carried out with oocyte
membranes, macroscopic recordings were carried out on
artificial lipid bilayers. Peptides were incorporated into
azolectine planar lipid bilayers according to the Montal–
Mueller technique [17]. Fig. 2 shows current–voltage (I–V)
curves recorded for Pα, Pβ and Pep-1 in 1 M KCl electrolyte
when applying a triangular voltage ramp to highly doped
bilayers (10−7 M). The different I–V curves show a non-
ohmic behaviour and present two distinct phases. Below a
voltage threshold, almost no transmembrane current can be
detected while a significant exponential development of
transmembrane current is observed above voltage threshold.
The voltage increment (Ve) resulting in an e-fold change in
conductance on the exponential branch of I–V curve is
characteristic of voltage dependence. Pα presents a Ve of
8.5 mV indicating a strong voltage dependence whereas Pβ
and Pep-1 have Ve values of 36 and 22 mV, respectively,
indicating a weaker voltage dependence. It should be noted
that transmembrane current is involved irrespective of the
delay between addition of the peptide and the first applied
ramp. Moreover, after applying several ramps, the I–V curves
become linear which is characteristic of an ohmic behaviour.
This latter observation clearly indicates that a voltage-
dependent membrane insertion or reorientation within the
membrane occurs for all peptides.
Single channel events could be detected in planar lipid
bilayers. Indeed, when doped with a low peptide concentra-
tion (10−10 M for Pep-1 and Pβ, 10−8 M for Pα), discrete
fluctuations of the transmembrane current were generated
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associated histogram shows a major channel conductance of
140 pS for Pα, 1260 pS for Pep-1 and several conductance
states of 950, 1150 and 1270 pS for Pβ in a 1 M KCl
medium. Owing to the broad conductance distribution of the
single channel events, no significant modification of the
conductances was detected when recorded in the presence of
the cargoes. It is likely that this is due to a partial decaging
occurring when working at low peptide concentrations as
required for single channel experiments.
3. Discussion and conclusion
In the present study we show that the two most efficient
transfecting peptides are able to induce pore formation when
incorporated into lipid bilayers. CD observations indicate that
the presence of lipid promotes formation of helical and β-sheet
structures for Pep-1 and Pβ, respectively, while Pα remains
helical irrespective of the environment. Reconstitution experi-
ments in oocytes show that Pβ and Pep-1 induce leakage
whereas Pα has no effect on these oocytes. Analysis of the
reversal potential indicates that the current is mainly carried by
the cations with a selectivity which varies slightly with the
nature of the peptide (K>Na>Choline>Li>TEA for Pβ and
K>Na>Li>Choline>TEA for Pep-1), the latter being similar
to the sequence already found for peptide P1 [19]. The Choline–Fig. 3. Single channel recordings induced by Pα, Pβ and Pep-1 in a lipid bilayer with t
10−8 M; applied voltage: +146 mV. (B) Pβ in POPC/DOPE/DOPG (7:3:1, v/v/v). Pep
Peptide concentration: 10−10 M; applied voltage: −67 mV. All recordings were perform
3000 Hz and a filter of 300 Hz.Li inversion may be related to the fact that some charged
residues are engaged in the so-called hydrophobic domain of
Pep-1.
In multi-channel experiments, the three peptides developed
I–V curves in planar lipid bilayers with more pronounced
exponential branches for Pα. The weak Ve value (8.5 mV)
observed for this peptide is close to the 6 mV obtained for
alamethicin [20] and indicates a strong voltage dependence. In
contrast, the Ve values of Pβ and Pep-1 (respectively 36 and
22 mV) are in agreement with a weaker voltage-dependence.
The lack of detectable activity of Pα in oocytes could be
explained by this difference in Ve values. Indeed in the case of
Pα, a higher voltage threshold is necessary to trigger the
exponential branch and pore formation. In oocytes, experiments
are performed with applied voltages which are too low to induce
ion flux. Moreover the single channel experiments with Pα
show that (i) a concentration of 10−8 M is necessary to observe
ion channels although a concentration of 10−10 M is sufficient
for Pβ and Pep-1; (ii) conductance values are very low for Pα
(140 pS in 1 M KCl) compared to those of Pβ and Pep-1 (above
1000 pS in 1 M KCl). The same classification is deduced from
the structural behaviours and cellular localizations of these
peptides. Indeed, Pep-1 and Pβ are extremely versatile from the
structural point of view; both are non-structured in water at low
concentrations (<10−4 M) and adopt an α-helical (Pep-1) and a
sheet (Pβ) structure in the presence of phospholipids.heir associated amplitude histogram. (A) Pα in azolectine. Peptide concentration:
tide concentration: 10−10 M; applied voltage: −143 mV. (C) Pep-1 in azolectine.
ed in KCl 1 M, buffered with 10 mMHEPES (pH 7.4) with a digitization rate of
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investigations [12] and mass spectrometry analysis [21],
indicate that Pα has a greater affinity for phospholipids than
Pβ, and that these interactions are driven by hydrophobic
forces. Indeed, penetration experiments carried out at the air–
water interface show that Pα promotes a larger increase in
phospholipid surface tension than Pβ and mass spectrometry
indicates that larger amounts of methanol are required to
dissociate Pα–phospholipid complexes than the complexes
formed with Pβ.
These findings are in line with the cellular internalizations
pathways promoted by these peptides, that it is endosome-
mediated for Pα, but neither for Pβ nor for Pep-1. Moreover,
these data, especially the peptide-induced transmembrane
currents agree with the models already proposed accounting
for the mechanism of cellular internalization of Pβ [14] and
Pep-1 [13] which occur in both cases through formation of pore-
like structures. For Pβ, the pore is mainly composed of a β-
barrel structure while for Pep-1 the pore is constituted of an
association of α-helices. In addition, the observation of a
peptide-induced voltage-dependent behaviour allows for for-
mulation of a more detailed mechanism, which suggests
potential-induced reorientation of the peptides, following
membrane insertion, once the hydrogen binding pattern has
been completed, ultimately leading to pore formation as
represented in Fig. 4. Indeed, except for Pα, the peptides are
not folded in aqueous media implying that the peptide bonds are
not engaged in hydrogen bonds, thereby precluding their
insertion into the hydrophobic layer of a membrane for
energetic reasons [22]. Owing to the ability of Pep-1 and Pβ
to fold into an α-helix and a β-sheet structure, respectively,
upon interaction with phospholipids their folding allows their
insertion into the membrane associated with a potential-
induced-transmembrane orientation of the folded domains,
i.e., the hydrophobic sequences as already reported for
penetratin [23,24]. Although these peptides are strongly
positively charged like other CPPs such as Tat [25,26] orFig. 4. Schematic representation of the proposed mechanism of membrane uptake a
association of several peptide molecules. State 1: the peptide is in solution in a non-fo
with the lipid headgroups (most likely through the charged residues) and folds. State 3
code for the peptides; red: hydrophobic domain; yellow: NLS.oligoarginines [27] which do not fold and therefore accumulate
at the membrane surface, the existence of a folded hydrophobic
domain precludes such accumulation and favours membrane
insertion. Finally, the driving force which dictates the
internalization pathway (via endosomes or not) is governed
by the affinity of the carrier peptide for phospholipids.
A priori, the differences between natural and artificial
membranes on the one hand, and between liposomes and a
planar bilayer on the other hand, appear inconsistent.
Nevertheless, the present observations point out differences
that can occur when examining different types of membranes.
A natural membrane such as that of oocytes is heterogenous
and has an almost unknown composition, which may have
drastic consequences on the nature of the peptide–lipid
interactions and thus on the possibilities of peptide self-
association without formation of an intermolecular hydrogen
bonding pattern.
As for the comparison between liposomes and planar bilayers,
the geometrical constraints found in liposomes may preclude
insertion of the peptide into the bilayer, especially when no
potential is applied. As an example, whilst the well known channel-
forming peptide gramicidin A [28,29] spontaneously inserts into
planar bilayers, it does not insert into liposome membranes and
insertion requires a sonication procedure [30].
The present results, especially the fact that a voltage-
dependent insertion is observed, seem in conflict with other
models which rule out the possibility of pore formation in the
case of Pep-1 [31–33]. The divergence in our conclusions is
indeed obvious and the explanation can be summarized as
follows: in the presence of liposomes, the geometrical
constrains together with the lack of applied potential prevent
insertion from occurring and therefore no pore can be formed.
As to origin of the difference between our results and those
reported by Henriques et al. [32,33], it arises from the fact that their
work was carried out using an N- and C-non protected peptide, at
least for the fluorescent derivative [34]. Since it is known that the
presence of the acetyl and cysteamide groups is a prerequisite fornd insertion of Pβ and Pep-1 before channel formation which is promoted by
lded state and does not interact with the membrane; State 2: the peptide interacts
: the transmenbrane potential promotes membrane insertion of the peptide. Color
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conclusion, especially with regard to pore formation.
In conclusion, the present work confirms that the cell-
penetrating peptides Pβ and Pep-1 are able to induce formation
of transmembrane pores which are most likely the basis for the
ability of these peptides to facilitate intracellular delivery of
therapeutics. Although Pα has been shown to form pores in
artificial bilayers, its behaviour when incorporated to oocytes is
in accordance with its cellular internalization pathway which is
endosome-mediated. In addition, the behaviour detected using
artificial membranes provides some information concerning
positioning of the peptides with respect to the membrane and
confirms the role of the potential in the translocation process.
Acknowledgments
Our thanks are due to Dr. M.C. Morris for her continuous
support and English corrections.
References
[1] G.P. Dietz, M. Bahr, Delivery of bioactive molecules into the cell: the
Trojan horse approach, Mol. Cell. Neurosci. 27 (2004) 85–131.
[2] I.M. Kaplan, J.S. Wadia, S.F. Dowdy, Cationic Tat peptide transduction
domain enters cells by macropinocytosis, J. Controlled Release 102 (2005)
247–253.
[3] J.P. Richard, K. Melikov, H. Brooks, P. Prevot, B. Lebleu, L.V.
Chernomordik, Cellular uptake of unconjugated TAT peptide involves
clathrin-dependent endocytosis and heparin sulfate receptors, J. Biol.
Chem. 280 (2005) 15300–15306.
[4] J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V.
Chernomordik, B. Lebleu, Cell-penetrating peptides. A reevaluation of the
mechanism of cellular uptake, J. Biol. Chem. 278 (2003) 585–590.
[5] M. Lundberg, M. Johansson, Is VP22 nuclear homing an artifact? Nat.
Biotechnol. 19 (2001) 713–714.
[6] M. Lundberg, S. Wikstrom, M. Johansson, Cell surface adherence and
endocytosis of protein transduction domains, Mol. Ther. 8 (2003)
143–150.
[7] M.C. Morris, P. Vidal, L. Chaloin, F. Heitz, G. Divita, A new peptide
vector for efficient delivery of oligonucleotides into mammalian cells,
Nucleic Acids Res. 25 (1997) 2730–2736.
[8] S. Deshayes, N. Van Mau, M.C. Morris, G. Divita, F. Heitz, Structural
requirements for non-covalent peptide-mediated cellular delivery of
siRNAs, in: M. Chorev, T.K. Sawyer (Eds.), Proceedings of the 18th
American Peptide Symposium, American Peptide Society, San Diego,
2004, pp. 802–804.
[9] M.C. Morris, J. Depollier, J. Mery, F. Heitz, G. Divita, A peptide carrier for
the delivery of biologically active proteins into mammalian cells, Nat.
Biotechnol. 19 (2001) 1173–1176.
[10] M.C. Morris, L. Chaloin, M. Choob, J. Archdeacon, F. Heitz, G. Divita,
Combination of a new generation of PNAs with a peptide-based carrier
enables efficient targeting of cell cycle progression, Gene Ther. 11 (2004)
757–764.
[11] F. Simeoni, M.C. Morris, F. Heitz, G. Divita, Insight into the mechanism of
the peptide-based gene delivery system MPG: implications for delivery of
siRNA into mammalian cells, Nucleic Acids Res. 31 (2003) 2717–2724.
[12] S. Deshayes, T. Plenat, G. Aldrian-Herrada, G. Divita, C. Le Grimellec, F.
Heitz, Primary amphipathic cell-penetrating peptides: structural require-
ments and interactions with model membranes, Biochemistry 43 (2004)
7698–7706.
[13] S. Deshayes, A. Heitz, M.C. Morris, P. Charnet, G. Divita, F. Heitz, Insight
into the mechanism of internalization of the cell-penetrating carrier peptidePep-1 through conformational analysis, Biochemistry 43 (2004)
1449–1457.
[14] S. Deshayes, S. Gerbal-Chaloin, M.C. Morris, G. Aldrian-Herrada, P.
Charnet, G. Divita, F. Heitz, On the mechanism of non-endosomial
peptide-mediated cellular delivery of nucleic acids, Biochim. Biophys.
Acta 1667 (2004) 141–147.
[15] P. Vidal, L. Chaloin, J. Mery, N. Lamb, N. Lautredou, R. Bennes, F. Heitz,
Solid-phase synthesis and cellular localization of a C- and/or N-terminal
labelled peptide, J. Pept. Sci. 2 (1996) 125–133.
[16] P. Charnet, E. Bourinet, S.J. Dubel, T.P. Snutch, J. Nargeot, Calcium
currents recorded from a neuronal alpha 1C L-type calcium channel in
Xenopus oocytes, FEBS Lett. 344 (1994) 87–90.
[17] M. Montal, P. Mueller, Formation of bimolecular membranes from lipid
monolayers and a study of their electrical properties, Proc. Natl. Acad. Sci.
U. S. A. 69 (1972) 3561–3566.
[18] M.C. Morris, P. Vidal, L. Chaloin, F. Heitz, G. Divita, A new peptide
vector for efficient delivery of oligonucleotide into nontransformed
mammalian cells, Nucleic Acid Res. 25 (1997) 2730–2736.
[19] L. Chaloin, E. De, P. Charnet, G. Molle, F. Heitz, Ionic channels formed by
primary amphipathic peptides, Biochim. Biophys. Acta 1375 (1998)
52–60.
[20] J.E. Hall, I. Vodyanoy, T.M. Balasubramanian, G.R. Marshall, Ala-
methicin. A rich model for channel behavior, Biophys. J. 45 (1984)
233–247.
[21] Y. Li, F. Heitz, C. Le Grimellec, R.B. Cole, Fusion peptide–phospholipid
noncovalent interactions as observed by nanoelectrospray FTICR-MS,
Anal. Chem. 77 (2005) 1556–1565.
[22] W.C. Wimley, S.H. White, Experimentally determined hydrophobicity
scale for proteins at membrane interfaces, Nat. Struct. Biol. 3 (1996)
842–848.
[23] D. Terrone, S.L. Sang, L. Roudaia, J.R. Silvius, Penetratin and related cell-
penetrating cationic peptides can translocate across lipid bilayers in the
presence of a transbilayer potential, Biochemistry 42 (2003)
13787–13799.
[24] H. Binder, G. Lindblom, Charge-dependent translocation of the Trojan
peptide penetratin across lipid membranes, Biophys. J. 85 (2003)
982–995.
[25] V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B.
Papahadjopoulos-Sternberg, G.G. D'Souza, Cell transfection in vitro and
in vivo with nontoxic TAT peptide–liposome–DNA complexes, Proc.
Natl. Acad. Sci. U. S. A. 100 (2003) 1972–1977.
[26] V.P. Torchilin, TAT peptide-modified liposomes for intracellular delivery
of drugs and DNA, Cell. Mol. Biol. Lett. 7 (2002) 265–267.
[27] J.B. Rothbard, T.C. Jessop, P.A. Wender, Adaptive translocation: the role
of hydrogen bonding and membrane potential in the uptake of
guanidinium-rich transporters into cells, Adv. Drug Deliv. Rev. 57
(2005) 495–504.
[28] S.B. Hladky, D.A. Haydon, Ion transfer across lipid membranes in the
presence of gramicidin A. I. Studies of the unit conductance channel,
Biochim. Biophys. Acta 274 (1972) 294–312.
[29] D.D. Busath, G. Szabo, Gramicidin forms multi-state rectifying channels,
Nature 294 (1981) 371–373.
[30] F. Heitz, Unpublished observations.
[31] K. Weller, S. Lauber, M. Lerch, A. Renaud, H.P. Merkle, O. Zerbe,
Biophysical and biological studies of end-group-modified derivatives of
Pep-1, Biochemistry 44 (2005) 15799–15811.
[32] S.T. Henriques, M.A. Castanho, Consequences of nonlytic membrane
perturbation to the translocation of the cell penetrating peptide Pep-1 in
lipidic vesicles, Biochemistry 43 (2004) 9716–9724.
[33] S.T. Henriques, J. Costa, M.A. Castanho, Translocation of beta-
galactosidase mediated by the cell-penetrating peptide pep-1 into lipid
vesicles and human HeLa cells is driven by membrane electrostatic
potential, Biochemistry 44 (2005) 10189–10198.
[34] S.T. Henriques, J. Costa, M.A. Castanho, Re-evaluating the role of
strongly charged sequences in amphipathic cell-penetrating peptides: a
fluorescence study using Pep-1, FEBS Lett. 579 (2005) 4498–4502.
